SRG’s interim results, its outlook, and the acquisition of Asset Care reinforces our positive view of the business and strategic direction. Recurring revenue is growing, organically and now acquisitively, underpinning near-term top-line growth while also extending visibility. We see full-year earnings accretion, before any synergies, from the acquisition, and our valuation lifts to $1.08 (prior $0.97). SRG is an ably led well rounded business. BUY.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
